Use of PET/MR Imaging in Chronic Pain

• Status: Recruiting
• Trial end date: 2025-01-31
• Target enrollment: 0
• Participant gender: All

Summary

The investigators are studying the ability of PET/MR imaging (using the PET tracer [18F]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Stanford University
• Collaborator: GE Healthcare
• Treatments: Fluorodeoxyglucose F18

Criteria

Inclusion Criteria:

• Age 18 years or older.

• Chronic pain lasting greater than 2 months. For example: Low back pain, sciatica, complex regional pain syndrome, peripheral nerve injury, fibromyalgia, neuropathy, osteoarthritis, cancer pain, persistent post-operative pain, and migraine.

• Provides informed consent

• On a typical day, pain level of at least 4/10 on a 0-10 Comparative Pain Scale

Exclusion Criteria:

• MRI-incompatible.

• Diabetes.

• Pregnant or nursing.

• Non-English speaker.